(Q44736805)

English

A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL). (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Diana Giannarelli

object named as

Diana Giannarelli

2

0 references

author name string

Stefano Molica

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Luciano Levato

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Rosanna Mirabelli

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Massimo Gentile

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Mirella Lentini

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Fortunato Morabito

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

27 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

290-295

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Monoclonal B-cell lymphocytosis: right track or red herring?

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

MBL versus CLL: how important is the distinction?

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Monoclonal B cell lymphocytosis and "in situ" lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines?

1 reference

https://api.crossref.org/works/10.1007%2FS12185-014-1634-7

21 January 2018

Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL

1 reference

https://pubmed.ncbi.nlm.nih.gov/25064370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25064370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features

1 reference

https://pubmed.ncbi.nlm.nih.gov/25064370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25064370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25064370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-014-1634-7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44736805&oldid=2206878273"